Abbott Laboratories news

   Watch this stock
Showing stories 1 - 10 of about 114   

Articles published

ABT 37.40 -0.60 (-1.59%)
price chart
Abbott Labs Is Boosting Its Diagnostic Business With This Big Buy
Abbott Laboratories ABT -2.22% said it would buy Alere ALR 45.16% for $5.8 billion in a deal that would expand its diagnostics business and make it a leader in point-of-care testing.
Abbott Labs' Good Timing  Bloomberg
Abbott Labs to buy Alere for $5.8 billion  MarketWatch
Why Abbott Laboratories Is Getting Crushed Today
What: Investors in Abbott Laboratories (NYSE:ABT) are having a rough day as shares of the diversified healthcare giant were down by as much as 10% as of 2:45 p.m.
Abbott Laboratories (ABT) Earnings Report: Q4 2015 Conference Call Transcript  TheStreet.com
Abbott Labs profit falls as strong dollar weighs  MarketWatch
Bridgewater Wealth & Financial Management LLC Raises Stake in Abbott ...
Abbott Laboratories logo Bridgewater Wealth & Financial Management LLC raised its position in Abbott Laboratories (NYSE:ABT) by 6.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
What Makes Abbott Laboratories (ABT) a Strong Sell?  Zacks.com
Top Stocks of the day: Abbott Laboratories (NYSE:ABT)  The News Journal
Stocks to Watch: Tesla, Chipotle, Aetna, Abbott Laboratories
Abbott Laboratories agreed to acquire diagnostic-test company Alere Inc. for roughly $4.8 billion, a deal Abbott expects will make it a leading provider of point-of-care testing.
Abbott Laboratories Hurt by Exchange Rates
A growing exchange-rate headwind in the past few months is expected to affect Abbott and many of its large-cap medical-technology peers.
Jefferies Group Lowers Abbott Laboratories (ABT) Price Target to $50.00  EMQ
Pennsylvania Trust Company Boosts Stake in Abbott Laboratories (ABT)  Corvus Business Newswire
Ex-Dividend Reminder: Yum! Brands, AbbVie and Abbott Laboratories
Looking at the universe of stocks we cover at Dividend Channel, on 1/13/16, Yum! Brands, Inc. (NYSE: YUM), AbbVie Inc. (NYSE: ABBV), and Abbott Laboratories (NYSE: ABT) will all trade ex-dividend for their respective upcoming dividends. Yum! Brands ...
Why Abbott Laboratories' Healthy Dividend Belongs on Your Radar  TheStreet.com
Abbott Laboratories (ABT) Stake Boosted by Union Bankshares  EMQ
AbbVie, Abbott Laboratories allegedly knew Depakote could cause birth defects
EAST ST. LOUIS–Eight plaintiffs from different states are suing two drugmakers over birth defects they say were caused when their mothers ingested an epilepsy medication while pregnant.
Abbott Labs (ABT) Beats on Q4 Earnings, Lags on Revenues
Abbott Labs expects earnings per share in the range of $2.10 to $2.20 per share in 2016, including a significant decrease in contribution from Venezuelan operations as a result of challenging market conditions in the country.
Abbott Labs Q4 sales up  Stock Market Wire
Abbott Laboratories (ABT) is Trading Lower on Unusual Volume for January 18
Abbott Laboratories (ABT) experienced unusually high volume on Jan. 18, as the stock lost 1.36% to a closing price of $40.54.
Abbott Laboratories (ABT) PT Lowered to $47.00 at Jefferies Group
Abbott Laboratories logo Abbott Laboratories (NYSE:ABT) had its price target trimmed by Jefferies Group from $50.00 to $47.00 in a report published on Wednesday, MarketBeat reports.